(+)-O,O'-Di-p-toluoyl-D-tartaric acid

CAS: 32634-68-7

Rif. 3D-FD22531

Informazioni sul prodotto

• Nome: (+)-O,O'-Di-p-toluoyl-D-tartaric acid
• Sinonimi: O,O'-Di-p-toluoyl-dg-tartaric acid(2S,3S)-(+)-Di-O-4-toluoyltartaric acid2,3-Bis-(4-methyl-benzoyloxy)-succinic acid, (+)-Bis-O,O′-(4-toluoyl)-<span class="text-smallcaps">D</span>-tartrate, (+)-Di-O,O′-p-toluoyltartaric acid, (+)-Di-O,O′-p-toluyltartaric acid, (+)-Di-O-(p-toluoyl)tartaric acid, (+)-Di-O-p-toluoyl-<span class="text-smallcaps">D</span>-tartaric acid, (+)-Di-p-toluoyl-<span class="text-smallcaps">D</span>-tartaric acid, (+)-Di-p-toluoyl-D-tartaric acid, (+)-Di-p-toluoyl-D-tartaric acid(Anhydrous), (+)-Di-p-toluoyltartaric acid, (+)-Ditoluoyltartaric acid, (+)-O,O-Di-p-toluoyltartaric acid, (+)-O,O′-Di-p-toluoyl-<span class="text-smallcaps">D</span>-tartaric acid, (-)-di-p-Toluyl-L-tartaric acid, (2S,35)-(-)-di-o-4-Toluoyl-D-tartaric acid, (2S,3S)-(+)-Di-p-toluoyltartaric acid, (2S,3S)-2,3-Bis[(4-methylbenzoyl)oxy]succinic acid, (2S,3S)-2,3-bis[(4-methylbenzoyl)oxy]butanedioic acid, (S,S)-O,O′-Di-p-toluoyltartaric acid, 2,3-Bis(4-Methylphenoxy)Butanedioic Acid, 2,3-Bis[(4-Methylbenzoyl)Oxy]-,[S-(Theta,Theta)]-Butanedioicaci, 2,3-Bis[(4-methylbenzoyl)oxy]succinic acid, 2,3-Bis{[(4-Methylphenyl)Carbonyl]Oxy}Butanedioic Acid Hydrate, 2,3-Di-O-Para-Toluoyl-D-Tartaricacidhydrate, 2,3-Di-O-para-toluoyl-D-tartaric acid, <span class="text-smallcaps">D</span>-Bis(O-4-methylbenzoyl)tartaric acid, <span class="text-smallcaps">D</span>-Di-O,O′-p-toluyltartaric acid, <span class="text-smallcaps">D</span>-Di-p-toluoyltartaric acid, Butanedioic acid, 2,3-bis((4-methylbenzoyl)oxy)-, (2S,3S)-, Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, [S-(R*,R*)]-, D-Dtta, Di-p-toluoyl-l-tartaric acid, L-di-p-Toluyltartaric acid, NSC 97592, Tartaric acid, di-p-toluate, (+)-, p-Toluic acid, diester with <span class="text-smallcaps">D</span>-tartaric acid
• CAS: 32634-68-7

Descrizione

(+)-O,O'-Di-p-toluoyl-D-tartaric acid is a potent and selective ligand for the dopamine D2 receptor. It was first synthesized in 1968 and has been extensively studied for its interactions with dopamine receptors. (+)-O,O'-Di-p-toluoyl-D-tartaric acid has been shown to be an orthosteric agonist at the D2 receptor, meaning it binds directly to the receptor in the absence of any other compounds. It binds to the extracellular site of the receptor, with a binding affinity that is 10 times more potent than that of apomorphine. The compound has been shown to have antidepressant effects when administered systemically, as well as in animal models of depression. This activity may be due to its ability to selectively activate dopamine D2 receptors in regions such as the prefrontal cortex.

• Marchio: Biosynth

Proprietà chimiche

• Peso molecolare: 386.35 g/mol
• Formula: C₂₀H₁₈O₈
• Purezza: Min. 95%
• Colore/Forma: Powder